Literature DB >> 13230471

Platelet agglutinins and lysins in the pathogenesis of thrombocytopenic purpura, with a note on platelet groups.

J F ACKROYD.   

Abstract

Entities:  

Keywords:  BLOOD PLATELETS; NEOPLASMS/etiology and pathogenesis; PURPURA, THROMBOPENIC/etiology and pathogenesis

Mesh:

Substances:

Year:  1955        PMID: 13230471     DOI: 10.1093/oxfordjournals.bmb.a069441

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


× No keyword cloud information.
  7 in total

1.  Precipitating auto-antibodies in the connective tissue diseases.

Authors:  J R ANDERSON; K G GRAY; J S BECK; W W BUCHANAN; A J McELHINNEY
Journal:  Ann Rheum Dis       Date:  1962-12       Impact factor: 19.103

2.  Immobilization of the knee joint in rheumatoid arthritis.

Authors:  R HARRIS; E P COPP
Journal:  Ann Rheum Dis       Date:  1962-12       Impact factor: 19.103

3.  Immunological reactions in gastrointestinal disease: a review.

Authors:  K B TAYLOR; S C TRUELOVE
Journal:  Gut       Date:  1962-12       Impact factor: 23.059

4.  [Immunothromcytopenia; a new field of immuno-hematology].

Authors:  J WEINREICH
Journal:  Klin Wochenschr       Date:  1955-06-01

5.  Immunoreactions involving platelets. I. A steric and kinetic model for formation of a complex from a human antibody, quinidine as a haptene, and platelets; and for fixation of complement by the complex.

Authors:  N R SHULMAN
Journal:  J Exp Med       Date:  1958-05-01       Impact factor: 14.307

6.  [Usefulness of kollidon for production of thrombocyte concentrations for transfusion purposes].

Authors:  M MATTHES; K SICKINGER
Journal:  Klin Wochenschr       Date:  1956-06-01

7.  IMMUNOREACTIONS INVOLVING PLATELETS. V. POST-TRANSFUSION PURPURA DUE TO A COMPLEMENT-FIXING ANTIBODY AGAINST A GENETICALLY CONTROLLED PLATELET ANTIGEN. A PROPOSED MECHANISM FOR THROMBOCYTOPENIA AND ITS RELEVANCE IN "AUTOIMMUNITY".

Authors:  N R Shulman; R H Aster; A Leitner; M C Hiller
Journal:  J Clin Invest       Date:  1961-09       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.